BioSpace News Archive

Umoja Biopharma, Inc. announced the appointment of Igor I. Slukvin, M.D., Ph.D. to its Scientific Advisory Board.

Palisade Bio, Inc. announced that Tom Hallam, Ph.D., Chief Executive Officer and Michael Dawson, M.D., Chief Medical Officer of Palisade Bio will present at the Virtual Investor Innovations in Intestinal Health - Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Event on Friday, September 16, 2022 at 11:00 AM ET.

Sagimet Biosciences announced today that it has completed enrollment of its Phase 2b liver biopsy-based clinical trial (“FASCINATE-2”) with denifanstat, a fatty acid synthase (FASN) inhibitor, in non-alcoholic steatohepatitis (NASH) patients.

n-Lorem, a nonprofit foundation, today announced that Solve FSHD has provided one million dollars in support of n-Lorem’s efforts to fully understand the complex molecular cause of facioscapulohumeral muscular dystrophy-2 (FSHD2).

IDEX Corporation announced that it has entered into a definitive agreement to acquire micro-precision technology manufacturing company Muon B.V. and its subsidiaries for cash consideration of €700 million.

The global Augmented and Virtual Reality in Healthcare market size was estimated at USD 2.3 billion in 2021 and is expected to surpass around USD 19.6 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 26.88% during the forecast period 2022 to 2030.

The European Patent Office granted OmniGuide with a new patent for its Laparoscopic Handpiece for FlexAssure CO2 Flexible Instruments (Patent Number 3193695).

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, is pleased to announce its participation in the 46th Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference & Exhibit at the Palm Beach County Convention Center in West Palm Beach, Florida on September 15 – 17, 2022.

FEMSelect, the developer of EnPlace®, a minimally invasive, meshless approach to pelvic floor ligament fixation, reported positive results in a four-year prospective follow-up evaluation of the system.

A recent study published in JAMA Network Open demonstrated that Lunit INSIGHT CXR, Lunit’s AI-powered chest x-ray analysis solution, can significantly improve the accuracy and efficiency of radiologists diagnosing major chest findings.